论文部分内容阅读
目的:分析循证药学在抗生素治疗方案及其临床效果。方法:选取2012年2月至2014年3月在四会市人民医院接受治疗的上呼吸道革兰阳性菌感染患者110例,随机分为观察组和对照组,两组上呼吸道革兰阳性菌感染患者均采用青霉素治疗,观察组则再实施循证药学,比较两组患者治疗后症状改善时间和总有效率。结果:观察组上呼吸道革兰阳性菌感染患者的症状改善时间和总有效率明显优于对照组上呼吸道革兰阳性菌感染患者,差异均具有统计学意义(P<0.05)。结论:在抗生素治疗方案和临床实践中实施循证药学,能够减少患者治疗后症状改善时间和提高患者治疗效果。
OBJECTIVE: To analyze evidence-based medicine in antibiotic treatment and its clinical effect. Methods: From February 2012 to March 2014 in Sihui People’s Hospital, 110 patients with upper respiratory tract Gram-positive bacteria infection were randomly divided into observation group and control group. The upper respiratory tract Gram-positive bacteria infection Patients were treated with penicillin, observation group then the implementation of evidence-based pharmacy, compared two groups of patients after treatment to improve the time and total effective rate. Results: The symptom improvement time and total effective rate of patients with Gram-positive bacteria in the upper respiratory tract of the observation group were significantly better than those of the control group with Gram-positive bacteria (P <0.05). CONCLUSIONS: The implementation of evidence-based pharmaco-therapy in antibiotic regimens and clinical practice can reduce the time it takes for patients to improve their symptoms and improve their outcomes.